ATC Abstracts

American Transplant Congress abstracts

2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions
View by Date

Saturday, June 2, 2018

5:30pm-7:30pm
Patient Change in Residence and Risk of Readmission after Renal Transplant in the US

J. Hogan, M. Anderson, Y. Zhang, J. Kim, G. Karadkhele, X. Zhang, A. Adams, R. Patzer.

Poster Session A: Non-Organ Specific: Disparities to Outcome and Access to Healthcare  •  Hall 4EF
5:30pm-7:30pm
Patients Converted to Belatacept Show Different Immunophenotyping Compared with De Novo Belatacept-Treated Patients

M. Rial,1 F. Caro,2 A. Nella,2 D. Guerrieri,2 L. León,1 P. Uva,1 E. Chuluyan,2 D. Casadei.1

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall 4EF
5:30pm-7:30pm
Peptides Encoded by EBV Latent Cycle Proteins Affect NK Cell Reactivity

B. Mbiribindi, C. Romero Moreno, C. Esquivel, O. Martinez, S. Krams.

Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement  •  Hall 4EF
5:30pm-7:30pm
Peri-Transplant Glycaemic Control as a Predictor of Pancreas Transplant Survival

M. Shapey,1,2 R. Tan,1 H. Khambalia,2 C. Fullwood,2 P. Yianoullou,1,2 A. Summers,2 T. Augustine,2 M. Rutter,1 D. van Dellen.2

Poster Session A: Pancreas and Islet: All Topics  •  Hall 4EF
5:30pm-7:30pm
Peripheral Blood Immune Response-Related Gene Analysis for Evaluating the Development of Subclinical Antibody-Mediated Rejection

T. Yamamoto,1 K. Iwasaki,2 K. Murotani,3 A. Takeda,4 M. Tsujita,4 T. Hiramitsu,4 N. Goto,4 S. Narumi,4 Y. Watarai,4 K. Uchida,2 T. Kobayashi.5

Poster Session A: Biomarkers, Immune Monitoring and Outcomes  •  Hall 4EF
5:30pm-7:30pm
Platelet Counts as Predictors of Short- and Long-Term Outcomes in Liver Transplantation: Cassandras or Just Rats on a Sinking Ship?

I. Amygdalos,1 Z. Czigany,1 J. Böcker,1 F. Meister,1 M. Krebbers,1 D. Morales Santana,1 J. Bednarsch,1 W. Schöning,1 F. Ulmer,1 G. Koek,3 D. Kroy,2 F. Tacke,2 C. Trautwein,2 U. Neumann,1 G. Lurje.1

Poster Session A: Liver Retransplantation and Other Complications  •  Hall 4EF
5:30pm-7:30pm
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience

D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.

Poster Session A: Liver Retransplantation and Other Complications  •  Hall 4EF
5:30pm-7:30pm
Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

F. Shihab,1 Y. Qazi,1 V. Peddi,1 D. Shaffer,1 K. McCague,2 D. Patel,2 S. Mulgaonkar.1

Poster Session A: Tolerance: Clinical Studies  •  Hall 4EF
5:30pm-7:30pm
Post-Transplant High Dose Cyclophosphamide Treatment Induces Thymus-Independent Immune Tolerance of Vascularized Composite Allografts via Complete Depletion of the Alloreactive TCR Repertoire.

G. Furtmüller,1 B. Oh,1 J. Sidhom,2 M. Fryer,1 V. Malek,1 X. Zhou,1 D. Cooney,1 C. Brayton,3 J. Dodd-o,4 S. Ganguly,2 G. Raimondi,1 W. Lee,1 L. Luznik,2 G. Brandacher.1

Poster Session A: Tolerance / Immune Deviation  •  Hall 4EF
5:30pm-7:30pm
Pre-Emptive Rituximab and Intravenous Immunoglobulin (IVIg) Fail to Prevent Rejection in Kidney Transplant Recipients (KTx) with Donor Specific Antibodies (DSA)

J. Crew, R. Vasilescu, E. Campenot, S. Mohan, S. Patel.

Poster Session A: Kidney Immunosuppression: Desensitization  •  Hall 4EF